ArticleClinicoEconomics and outcomes research : CEOR2020

Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe.

Katharina Verleger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.